By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sorrento Therapeutics, Inc. 



San Diego  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Sorrento Therapeutics, Inc. Awarded Grant From The National Institutes of Health (NIH) For The Development Of A Small Molecule Myc Inhibitor 7/21/2014 1:05:19 PM
Sorrento Therapeutics, Inc. Awarded Grant From The National Institutes Of Health For The Development Of A Small Molecule Myc Inhibitor 7/21/2014 12:52:49 PM
Sorrento Therapeutics, Inc. Awarded Up To $2.6 Million From The National Institutes of Health (NIH) For The Development Of New Anti-Bacterial Bispecific Antibodies And Antibody Formulated Drug Conjugates 7/1/2014 11:13:06 AM
Morphotek Inc. And Sorrento Therapeutics, Inc. Sign An Exclusive Research And Option Agreement To Generate And Develop Morphotek Antibody Drug Conjugates 6/25/2014 7:04:46 AM
Sorrento Therapeutics, Inc. Announces Confidential Submission Of Draft Registration Statement For Initial Public Offering (IPO) Of Its Wholly-Owned Subsidiary Ark Animal Health With The SEC 6/23/2014 7:39:56 AM
Sorrento Therapeutics, Inc. To Present At Biotechnology Industry Organization (BIO) Business Forum 6/23/2014 6:24:46 AM
Sorrento Therapeutics, Inc. Announces Underwriters' Exercise Of Over-Allotment Option 6/13/2014 7:55:16 AM
Sorrento Therapeutics, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference 6/2/2014 6:23:39 AM
Sorrento Therapeutics, Inc. Announces Proposed Public Offering Of Common Stock 5/14/2014 12:25:41 PM
Sorrento Therapeutics, Inc. Announces Transfer Of Orphan Drug Designation Sponsorship for Intrathecal Resiniferatoxin From National Institutes of Health (NIH) 5/13/2014 9:27:33 AM
1234567
//-->